Anti Xa monitoring during treatment with low molecular weight heparin or danaparoid: inter-assay variability.

Kitchen, S

Anti Xa monitoring during treatment with low molecular weight heparin or danaparoid: inter-assay variability. [electronic resource] - Thrombosis and haemostasis Oct 1999 - 1289-93 p. digital

Publication Type: Journal Article

0340-6245


Antibodies--blood
Drug Monitoring
Factor Xa--immunology
Heparin, Low-Molecular-Weight--immunology
Humans
Thrombosis--blood